<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.3?>
<?ConverterInfo.XSLTName nlm2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="hwp">nar</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">4383898</article-id>
    <article-id pub-id-type="pmid">25378316</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gku1056</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>IMGT<sup>®</sup>, the international ImMunoGeneTics information system<sup>®</sup> 25 years on</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Lefranc</surname>
          <given-names>Marie-Paule</given-names>
        </name>
        <xref rid="COR1" ref-type="corresp">*</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Giudicelli</surname>
          <given-names>Véronique</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Duroux</surname>
          <given-names>Patrice</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jabado-Michaloud</surname>
          <given-names>Joumana</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Folch</surname>
          <given-names>Géraldine</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Aouinti</surname>
          <given-names>Safa</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Carillon</surname>
          <given-names>Emilie</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Duvergey</surname>
          <given-names>Hugo</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Houles</surname>
          <given-names>Amélie</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Paysan-Lafosse</surname>
          <given-names>Typhaine</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hadi-Saljoqi</surname>
          <given-names>Saida</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sasorith</surname>
          <given-names>Souphatta</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lefranc</surname>
          <given-names>Gérard</given-names>
        </name>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Kossida</surname>
          <given-names>Sofia</given-names>
        </name>
        <xref rid="COR2" ref-type="corresp">*</xref>
      </contrib>
      <aff id="AFF1">IMGT<sup>®</sup>, the international ImMunoGeneTics information system<sup>®</sup>, Université de Montpellier, Laboratoire d'ImmunoGénétique Moléculaire LIGM, UPR CNRS 1142, Institut de Génétique Humaine IGH, 141 rue de la Cardonille, Montpellier, 34396 cedex 5, France</aff>
    </contrib-group>
    <author-notes>
      <corresp id="COR1"><label>*</label>To whom correspondence should be addressed. Tel: +33 4 34 35 99 65; Fax: +33 4 34 35 99 01; Email: <email>Marie-Paule.Lefranc@igh.cnrs.fr</email></corresp>
      <corresp id="COR2">Correspondence may also be addressed to Sofia Kossida. Tel: +33 4 34 35 99 65; Fax: +33 4 34 35 99 01; Email: <email>Sofia.Kossida@igh.cnrs.fr</email></corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>05</day>
      <month>11</month>
      <year>2014</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <day>28</day>
      <month>1</month>
      <year>2015</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>05</day>
      <month>11</month>
      <year>2014</year>
    </pub-date>
    <volume>43</volume>
    <issue>Database issue</issue>
    <issue-title>Database issue</issue-title>
    <fpage>D413</fpage>
    <lpage>D422</lpage>
    <history>
      <date date-type="accepted">
        <day>13</day>
        <month>10</month>
        <year>2014</year>
      </date>
      <date date-type="received">
        <day>25</day>
        <month>9</month>
        <year>2014</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2015</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:title="pdf" xlink:href="gku1056.pdf"/>
    <abstract>
      <p>IMGT<sup>®</sup>, the international ImMunoGeneTics information system<sup>®</sup>(<ext-link xlink:href="http://www.imgt.org" ext-link-type="uri">http://www.imgt.org</ext-link>) is the global reference in immunogenetics and immunoinformatics. By its creation in 1989 by Marie-Paule Lefranc (Université de Montpellier and CNRS), IMGT<sup>®</sup> marked the advent of immunoinformatics, which emerged at the interface between immunogenetics and bioinformatics. IMGT<sup>®</sup> is specialized in the immunoglobulins (IG) or antibodies, T cell receptors (TR), major histocompatibility (MH) and proteins of the IgSF and MhSF superfamilies. IMGT<sup>®</sup> is built on the IMGT-ONTOLOGY axioms and concepts, which bridged the gap between genes, sequences and 3D structures. The concepts include the IMGT<sup>®</sup> standardized keywords (identification), IMGT<sup>®</sup> standardized labels (description), IMGT<sup>®</sup> standardized nomenclature (classification), IMGT unique numbering and IMGT Colliers de Perles (numerotation). IMGT<sup>®</sup> comprises 7 databases, 17 online tools and 15 000 pages of web resources, and provides a high-quality and integrated system for analysis of the genomic and expressed IG and TR repertoire of the adaptive immune responses, including NGS high-throughput data. Tools and databases are used in basic, veterinary and medical research, in clinical applications (mutation analysis in leukemia and lymphoma) and in antibody engineering and humanization. The IMGT/mAb-DB interface was developed for therapeutic antibodies and fusion proteins for immunological applications (FPIA). IMGT<sup>®</sup> is freely available at <ext-link xlink:href="http://www.imgt.org" ext-link-type="uri">http://www.imgt.org</ext-link>.</p>
    </abstract>
    <counts>
      <page-count count="10"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>cover-date</meta-name>
        <meta-value>28 January 2015</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>IMGT<sup>®</sup>, the international ImMunoGeneTics information system<sup>®</sup> (<ext-link xlink:href="http://www.imgt.org" ext-link-type="uri">http://www.imgt.org</ext-link>) (<xref rid="B1" ref-type="bibr">1</xref>), was created in 1989 by Marie-Paule Lefranc at Montpellier, France (Université de Montpellier and CNRS). The founding of IMGT<sup>®</sup> marked the advent of immunoinformatics, a new science, which emerged at the interface between immunogenetics and bioinformatics (<xref rid="B2" ref-type="bibr">2</xref>). For the first time, immunoglobulin (IG) or antibody and T cell receptor (TR) variable (V), diversity (D), joining (J) and constant (C) genes were officially recognized as ‘genes’ as well as the conventional genes (<xref rid="B3" ref-type="bibr">3</xref>–<xref rid="B6" ref-type="bibr">6</xref>). This major breakthrough allowed genes and data of the complex and highly diversified adaptive immune responses to be managed in genomic databases and tools.</p>
    <p>IMGT<sup>®</sup> manages the diversity and complexity of the IG and TR genes and proteins and the polymorphism of the major histocompatibility (MH) proteins of humans and other vertebrates. IMGT<sup>®</sup> is also specialized in the other proteins of the immunoglobulin superfamily (IgSF) and MH superfamily (MhSF) and related proteins of the immune system (RPI) of vertebrates and invertebrates (<xref rid="B1" ref-type="bibr">1</xref>). IMGT<sup>®</sup> provides a common access to standardized data from genome, proteome, genetics, two-dimensional (2D) and three-dimensional (3D) structures. IMGT<sup>®</sup> is the acknowledged high-quality integrated knowledge resource in immunogenetics for exploring immune functional genomics.</p>
    <p>IMGT<sup>®</sup> comprises 7 databases (<xref rid="B7" ref-type="bibr">7</xref>–<xref rid="B12" ref-type="bibr">12</xref>), 17 online tools (<xref rid="B13" ref-type="bibr">13</xref>–<xref rid="B28" ref-type="bibr">28</xref>) and more than 15 000 pages of web resources (Figure <xref rid="F1" ref-type="fig">1</xref>). Databases include IMGT/LIGM-DB (175 898 entries from 346 species) (<xref rid="B7" ref-type="bibr">7</xref>), IMGT/CLL-DB and IMGT/PRIMER-DB for nucleotide sequences and their translation, IMGT/GENE-DB (3431 genes, 5079 alleles) (<xref rid="B8" ref-type="bibr">8</xref>) for genes, IMGT/3Dstructure-DB and IMGT/2Dstructure-DB (3682 entries) (<xref rid="B9" ref-type="bibr">9</xref>–<xref rid="B11" ref-type="bibr">11</xref>) for structures and IMGT/mAb-DB (488 entries) (<xref rid="B12" ref-type="bibr">12</xref>) for therapeutic antibodies and fusion proteins for immunological applications (FPIA). The tools are for sequence, gene and structure analysis (<xref rid="B13" ref-type="bibr">13</xref>–<xref rid="B28" ref-type="bibr">28</xref>) (Figure <xref rid="F1" ref-type="fig">1</xref>). The web resources include several major sections, for example, IMGT Scientific chart, IMGT Repertoire, IMGT Education &gt; Aide-mémoire (<xref rid="B29" ref-type="bibr">29</xref>), The IMGT Medical page, The IMGT Veterinary page, The IMGT Biotechnology page, The IMGT Immunoinformatics page (<xref rid="B1" ref-type="bibr">1</xref>).</p>
    <fig position="float" id="F1">
      <label>Figure 1.</label>
      <caption>
        <p>IMGT<sup>®</sup>, the international ImMunoGeneTics information system<sup>®</sup>, <ext-link xlink:href="http://www.imgt.org" ext-link-type="uri">http://www.imgt.org</ext-link>. Databases are shown as cylinders and tools as rectangles. The web resources are not shown.</p>
      </caption>
      <graphic xlink:href="gku1056fig1" position="float"/>
    </fig>
    <p>IMGT<sup>®</sup> is the global reference in immunogenetics and immunoinformatics (<xref rid="B30" ref-type="bibr">30</xref>–<xref rid="B36" ref-type="bibr">36</xref>). Its standards have been endorsed by the World Health Organization-International Union of Immunological Societies (WHO-IUIS) Nomenclature Committee since 1995 (first IMGT<sup>®</sup> online access at the 9th International Congress of Immunology, San Francisco, USA) (<xref rid="B37" ref-type="bibr">37</xref>,<xref rid="B38" ref-type="bibr">38</xref>) and the WHO International Nonproprietary Names (INN) Programme (<xref rid="B39" ref-type="bibr">39</xref>,<xref rid="B40" ref-type="bibr">40</xref>) for the description of therapeutic antibodies.</p>
  </sec>
  <sec id="SEC2">
    <title>IMGT-ONTOLOGY</title>
    <p>The accuracy and the consistency of the IMGT<sup>®</sup> data are based on IMGT-ONTOLOGY (<xref rid="B41" ref-type="bibr">41</xref>–<xref rid="B43" ref-type="bibr">43</xref>), the first, and so far, unique ontology for immunogenetics and immunoinformatics. IMGT-ONTOLOGY manages the immunogenetics knowledge through diverse facets that rely on seven axioms: IDENTIFICATION, DESCRIPTION, CLASSIFICATION, NUMEROTATION, LOCALIZATION, ORIENTATION and OBTENTION (<xref rid="B42" ref-type="bibr">42</xref>). The concepts generated from these axioms led to the elaboration of the IMGT<sup>®</sup> standards that constitute the IMGT Scientific chart: e.g. IMGT® standardized keywords (IDENTIFICATION axiom and concepts of identification) (<xref rid="B44" ref-type="bibr">44</xref>), IMGT<sup>®</sup> standardized labels (DESCRIPTION axiom and concepts of description) (<xref rid="B45" ref-type="bibr">45</xref>), IMGT<sup>®</sup> standardized gene and allele nomenclature (CLASSIFICATION axiom and concepts of classification) (<xref rid="B46" ref-type="bibr">46</xref>), IMGT unique numbering (<xref rid="B47" ref-type="bibr">47</xref>–<xref rid="B52" ref-type="bibr">52</xref>) and its standardized graphical 2D representation or IMGT Colliers de Perles (<xref rid="B53" ref-type="bibr">53</xref>–<xref rid="B57" ref-type="bibr">57</xref>) (NUMEROTATION axiom and concepts of numerotation).</p>
    <sec id="SEC2-1">
      <title>IDENTIFICATION: IMGT<sup>®</sup> standardized keywords</title>
      <p>More than 325 IMGT<sup>®</sup> standardized keywords (189 for sequences and 137 for 3D structures) were precisely defined (<xref rid="B44" ref-type="bibr">44</xref>). They represent the controlled vocabulary assigned during the annotation process and allow standardized search criteria for querying the IMGT<sup>®</sup> databases and for the extraction of sequences and 3D structures. They have been entered in BioPortal at the National Center for Biomedical Ontology (NCBO) in 2010 (<ext-link xlink:href="http://bioportal.bioontology.org/ontologies/1491" ext-link-type="uri">http://bioportal.bioontology.org/ontologies/IMGT-ONTOLOGY</ext-link>).</p>
      <p>Standardized keywords assigned to a nucleotide sequence are found in the ‘DE’ (definition) and ‘KW’ (keyword) lines of the IMGT/LIGM-DB files (<xref rid="B7" ref-type="bibr">7</xref>). They characterize for instance the gene type, the configuration type and the functionality type (<xref rid="B44" ref-type="bibr">44</xref>). There are six gene types: variable (V), diversity (D), joining (J), constant (C), conventional-with-leader, conventional-without-leader. Four of them (V, D, J and C) identify the IG and TR genes and are specific to immunogenetics. There are four configuration types: germline (for the V, D and J genes before DNA rearrangement), rearranged (for the V, D and J genes after DNA rearrangement), partially rearranged (for D gene after only one DNA rearrangement) and undefined (for the C gene and for the conventional genes which do not rearrange). The functionality type depends on the gene configuration. The functionality type of genes in germline or undefined configuration is functional (F), ORF (for ‘open reading frame’) or pseudogene (P). The functionality type of genes in rearranged or partially rearranged configuration is either productive (no stop codon in the V-(D)-J region and in-frame junction) or unproductive (stop codon(s) in the V-(D)-J region, and/or out-of-frame junction).</p>
      <p>The 20 usual amino acids (AA) have been classified in 11 IMGT physicochemical classes (IMGT<sup>®</sup>
<ext-link xlink:href="http://www.imgt.org" ext-link-type="uri">http://www.imgt.org</ext-link>, IMGT Education &gt; Aide-mémoire &gt; Amino acids). The AA changes are identified according to the hydropathy (3 classes), volume (5 classes) and IMGT physicochemical classes (11 classes) (<xref rid="B29" ref-type="bibr">29</xref>). For example Q1 &gt; E (+ + −) means that in the AA change (Q &gt; E), the two AA at codon 1 belong to the same hydropathy (+) and volume (+) classes but to different IMGT physicochemical properties (−) classes (<xref rid="B29" ref-type="bibr">29</xref>). Four types of AA changes are identified in IMGT<sup>®</sup>: very similar (+ + +), similar (+ + −, + − +), dissimilar (− − +, − + −, + − −) and very dissimilar (− − −).</p>
    </sec>
    <sec id="SEC2-2">
      <title>DESCRIPTION: IMGT® standardized labels</title>
      <p>More than 560 IMGT<sup>®</sup> standardized labels (277 for sequences and 285 for 3D structures) were precisely defined (<xref rid="B45" ref-type="bibr">45</xref>). They are written in capital letters (no plural) to be recognizable without creating new terms. These labels are necessary for a standardized description of the IG, TR and MH sequences and structures in databases and tools (<xref rid="B45" ref-type="bibr">45</xref>). Standardized labels assigned to the description of sequences are found in the ‘FT’ (feature) lines of the IMGT/LIGM-DB files (<xref rid="B7" ref-type="bibr">7</xref>). Querying these labels represent a big plus compared to the generalist databases (GenBank/European Nucleotide Archive/DNA Data Bank of Japan). Thus, it is possible to query for the ‘CDR3-IMGT’ of the human rearranged productive sequences of IG-Heavy-Gamma (e.g. 1788 CDR3-IMGT obtained, with their sequences at the nucleotide or AA level). There are four core labels for IG and TR, that are V-REGION, D-REGION, J-REGION and C-REGION and which correspond to the coding region of the V, D, J and C genes, respectively. IMGT<sup>®</sup> structure labels were defined for IG, TR and MH receptors, chains and domains (<xref rid="B9" ref-type="bibr">9</xref>–<xref rid="B11" ref-type="bibr">11</xref>). A precise and detailed correspondence between structure and sequence labels (<xref rid="B2" ref-type="bibr">2</xref>) has contributed to the seamless bridging between sequence and structure data in IMGT<sup>®</sup> (<xref rid="B2" ref-type="bibr">2</xref>) and has strengthened the development of the IMGT domain-centric approach for the V, C and G domains (<xref rid="B57" ref-type="bibr">57</xref>).</p>
      <p>IMGT<sup>®</sup> labels were also defined for highly conserved AA at a given position in a domain (<xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B57" ref-type="bibr">57</xref>). Thus, of the four highly conserved AA between the V and C domains, three have a label: 1st-CYS (cysteine C at position <xref rid="B23" ref-type="bibr">23</xref>), CONSERVED-TRP (tryptophan W at position 41) and 2nd-CYS (C at position 104) (<xref rid="B48" ref-type="bibr">48</xref>–<xref rid="B50" ref-type="bibr">50</xref>,<xref rid="B52" ref-type="bibr">52</xref>,<xref rid="B57" ref-type="bibr">57</xref>). In addition, two alternative labels, J-PHE or J-TRP, are characteristics of the IG and TR V-DOMAIN and correspond to the first AA of the canonical F/W-G-X-G motif (where F is phenylalanine, W tryptophan, G glycine and X any AA) encoded by the J-REGION, with F or W being at position 118 (<xref rid="B48" ref-type="bibr">48</xref>,<xref rid="B49" ref-type="bibr">49</xref>,<xref rid="B52" ref-type="bibr">52</xref>,<xref rid="B57" ref-type="bibr">57</xref>).</p>
    </sec>
    <sec id="SEC2-3">
      <title>CLASSIFICATION: IMGT<sup>®</sup> standardized genes and alleles</title>
      <p>The IMGT-ONTOLOGY CLASSIFICATION axiom was the trigger of immunoinformatics’ birth (<xref rid="B2" ref-type="bibr">2</xref>). The IMGT<sup>®</sup>concepts of classification allowed, for the first time, to classify the antigen receptor genes (IG and TR) for any locus (e.g. IG heavy (IGH), TR alpha (TRA)), for any gene configuration (germline, undefined or rearranged) and for any species (from fishes to humans) (<xref rid="B3" ref-type="bibr">3</xref>–<xref rid="B6" ref-type="bibr">6</xref>). In higher vertebrates, there are seven IG and TR major loci (other loci correspond to chromosomal orphon sets, genes of which are orphons, not used in the IG or TR chain synthesis) (<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>). The IG major loci include the IGH, and for the light chains, the IG kappa (IGK) and the IG lambda (IGL) in higher vertebrates (<xref rid="B3" ref-type="bibr">3</xref>) and the IG iota (IGI) in fishes (IMGT<sup>®</sup>
<ext-link xlink:href="http://www.imgt.org" ext-link-type="uri">http://www.imgt.org</ext-link>, IMGT Repertoire). Since the creation of IMGT<sup>®</sup> in 1989, at New Haven during the 10th Human Genome Mapping Workshop (HGM10), the standardized classification and nomenclature of the IG and TR of humans and other vertebrate species have been under the responsibility of the IMGT Nomenclature Committee (IMGT-NC).</p>
      <p>IMGT<sup>®</sup> gene and allele names are based on the concepts of classification of ‘Group’, ‘Subgroup’, ‘Gene’ and ‘Allele’ (<xref rid="B46" ref-type="bibr">46</xref>). IMGT-ONTOLOGY concepts of classification have been entered in the NCBO BioPortal. New IG and TR genes and alleles are submitted to the IMGT-NC for approval.</p>
      <p>The IMGT<sup>®</sup> IG and TR gene names (<xref rid="B2" ref-type="bibr">2</xref>–<xref rid="B6" ref-type="bibr">6</xref>) are endorsed by the Human Genome Organisation (HUGO) Nomenclature Committee (HGNC) (<xref rid="B58" ref-type="bibr">58</xref>,<xref rid="B59" ref-type="bibr">59</xref>) and the WHO-IUIS Nomenclature Subcommittee for IG and TR (<xref rid="B37" ref-type="bibr">37</xref>,<xref rid="B38" ref-type="bibr">38</xref>). The IMGT<sup>®</sup> IG and TR gene names are the official international reference and, as such, are entered in IMGT/GENE-DB (<xref rid="B8" ref-type="bibr">8</xref>), in Gene (NCBI) (<xref rid="B60" ref-type="bibr">60</xref>), in NCBI MapViewer, in Ensembl (<xref rid="B61" ref-type="bibr">61</xref>) at the European Bioinformatics Institute and in the Vertebrate Genome Annotation (Vega) Browser (<xref rid="B62" ref-type="bibr">62</xref>) at the Wellcome Trust Sanger Institute (UK). HGNC, Gene NCBI, Ensembl and Vega have direct links to IMGT/GENE-DB (<xref rid="B8" ref-type="bibr">8</xref>). IMGT<sup>®</sup> human IG and TR genes were also integrated in IMGT-ONTOLOGY on the NCBO BioPortal and, on the same site, in the HUGO ontology and in the National Cancer Institute Metathesaurus. Since 2007, IMGT<sup>®</sup> gene and allele names have been used for the description of the therapeutic mAb and FPIA of the WHO-INN programme (<xref rid="B39" ref-type="bibr">39</xref>,<xref rid="B40" ref-type="bibr">40</xref>).</p>
    </sec>
    <sec id="SEC2-4">
      <title>NUMEROTATION: IMGT unique numbering and IMGT Collier de Perles</title>
      <p>The IMGT-ONTOLOGY NUMEROTATION axiom is acknowledged as the ‘IMGT<sup>®</sup> Rosetta stone’ that has bridged the biological and computational spheres in bioinformatics (<xref rid="B31" ref-type="bibr">31</xref>). The IMGT<sup>®</sup> concepts of numerotation comprise the IMGT unique numbering (<xref rid="B47" ref-type="bibr">47</xref>–<xref rid="B52" ref-type="bibr">52</xref>) and its graphical 2D representation the IMGT Collier de Perles (<xref rid="B53" ref-type="bibr">53</xref>–<xref rid="B57" ref-type="bibr">57</xref>). Developed for and by the ‘domain’, these concepts integrate sequences, structures and interactions into a standardized domain-centric knowledge for functional genomics. The IMGT unique numbering has been defined for the variable V domain (V-DOMAIN of the IG and TR, and V-LIKE-DOMAIN of IgSF other than IG and TR) (<xref rid="B47" ref-type="bibr">47</xref>–<xref rid="B49" ref-type="bibr">49</xref>), the constant C domain (C-DOMAIN of the IG and TR, and C-LIKE-DOMAIN of IgSF other than IG and TR) (<xref rid="B50" ref-type="bibr">50</xref>) and the groove G domain (G-DOMAIN of the MH, and G-LIKE-DOMAIN of MhSF other than MH) (<xref rid="B51" ref-type="bibr">51</xref>). Thus, the IMGT unique numbering and IMGT Collier de Perles provide a definitive and universal system across species including invertebrates, for the sequences and structures of the V, C and G domains of IG, TR and MH, and more generally of the IgSF and MhSF superfamilies (<xref rid="B57" ref-type="bibr">57</xref>).</p>
    </sec>
  </sec>
  <sec id="SEC3">
    <title>INTERACTION BETWEEN IMGT<sup>®</sup> DATABASES AND TOOLS</title>
    <p>IMGT<sup>®</sup> comprises 7 databases and 17 online tools for sequences, genes and structures which have been described in details, previously (<xref rid="B7" ref-type="bibr">7</xref>–<xref rid="B28" ref-type="bibr">28</xref>). Links to documentation, releases and statistics are available from the IMGT<sup>®</sup> Home page, <ext-link xlink:href="http://www.imgt.org" ext-link-type="uri">http://www.imgt.org</ext-link>. Here, we will focus mainly on examples demonstrating the strong interactions which exist between IMGT<sup>®</sup> databases and tools, based on the IMGT<sup>®</sup> rules and standards, generated from the IMGT-ONTOLOGY axioms and concepts and described in the IMGT Scientific chart. First, we will describe briefly the IMGT<sup>®</sup> reference directory databases that support the most popular tools for sequence analysis, then we will describe how the IMGT/3Dstructure-DB and IMGT/2Dstructure-DB databases are intimately associated with tool functionalities/results. These databases that bridge the gap between AA sequences and 3D structures can also be accessed by querying the IMGT/mAb-DB interface.</p>
    <sec id="SEC3-1">
      <title>IMGT<sup>®</sup> reference directory databases</title>
      <sec id="SEC3-1-1">
        <title>IMGT/V-QUEST reference directory</title>
        <p>IMGT/V-QUEST (<xref rid="B13" ref-type="bibr">13</xref>–<xref rid="B18" ref-type="bibr">18</xref>) and its high-throughput version, IMGT/HighV-QUEST (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B24" ref-type="bibr">24</xref>) analyse nucleotide sequences of the IG and TR variable domains. These tools run against the IMGT/V-QUEST reference directory database (Table <xref rid="tbl1" ref-type="table">1</xref>) that includes several sets. These sets comprise IMGT reference sequences from all functional (F) genes and alleles, all ORF and all in-frame pseudogenes (P) alleles from IMGT/GENE-DB (8). By definition, the IMGT reference directory sets contain one sequence for each allele. By default, the user sequences are compared with all genes and alleles. However, the IMGT/V-QUEST and IMGT/HighV-QUEST option ‘With allele *01 only’ can be useful if the user sequences need to be compared with different genes or if the user sequences that use the same gene need to be aligned together (independently of the allelic polymorphism) (<xref rid="B13" ref-type="bibr">13</xref>–<xref rid="B18" ref-type="bibr">18</xref>).</p>
        <table-wrap position="float" id="tbl1">
          <label>Table 1.</label>
          <caption>
            <title>IMGT<sup>®</sup> reference directory databases for IMGT<sup>®</sup> tools for analysis of V, C or G domains (nucleotide and AA sequences)</title>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">IMGT<sup>®</sup> reference directory databases</th>
                <th align="left" rowspan="1" colspan="1">IMGT<sup>®</sup> tools</th>
                <th align="left" rowspan="1" colspan="1">Entry types and examples of applications</th>
                <th align="left" rowspan="1" colspan="1">Results for V, C or G domains<sup>a</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">IMGT/V-QUEST reference directory</td>
                <td align="left" rowspan="1" colspan="1">IMGT/V-QUEST (<xref rid="B13" ref-type="bibr">13</xref>–<xref rid="B18" ref-type="bibr">18</xref>)</td>
                <td align="left" rowspan="1" colspan="1">User nucleotide sequences of V-DOMAIN (1 to 50 sequences per analysis, and 1 to 10 sequences with the option ‘Search for insertions and deletions’) (<xref rid="B17" ref-type="bibr">17</xref>)</td>
                <td align="left" rowspan="1" colspan="1">1. Introduction of IMGT gaps</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"><bold><italic>Applications:</italic></bold> somatic mutations in chronic lymphocytic leukemia (CLL) prognostic.</td>
                <td align="left" rowspan="1" colspan="1">2. Identification of the closest germline V, D and J genes and alleles</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">3. IMGT/JunctionAnalysis results (<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B20" ref-type="bibr">20</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">4. Translation in different formats</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">5. Description of mutations and AA changes</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">6. Identification of indels and their correction (<xref rid="B17" ref-type="bibr">17</xref>) (option).</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">7. IMGT/Automat annotation (<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">8. IMGT Colliers de Perles (<xref rid="B27" ref-type="bibr">27</xref>).</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">IMGT/HighV-QUEST (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B24" ref-type="bibr">24</xref>)</td>
                <td align="left" rowspan="1" colspan="1">User NGS nucleotide sequences of V-DOMAIN (up to 500,000 sequences per run)<sup>b</sup> (<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B24" ref-type="bibr">24</xref>)</td>
                <td align="left" rowspan="1" colspan="1">1. Introduction of IMGT gaps</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"><bold><italic>Applications:</italic></bold> IG and TR immune repertoires and clonotypes in NGS.</td>
                <td align="left" rowspan="1" colspan="1">2. Identification of indels and their correction (<xref rid="B18" ref-type="bibr">18</xref>) (by default)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">3. Identification of the closest germline V, D and J genes and alleles</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">4. Translation in different formats</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">5. IMGT/JunctionAnalysis results (<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B20" ref-type="bibr">20</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">6. Description of mutations and AA changes</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">7. IMGT/Automat annotation (<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">8. Statistical analysis (<xref rid="B24" ref-type="bibr">24</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">9. Characterization of the IMGT clonotypes (AA), clonal diversity and expression (<xref rid="B24" ref-type="bibr">24</xref>).</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">IMGT/DomainSeq reference directory</td>
                <td align="left" rowspan="1" colspan="1">IMGT/DomainGapAlign (<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>)</td>
                <td align="left" rowspan="1" colspan="1">User AA sequences of V, C and G domains (one to several sequences of same domain type) (<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>)</td>
                <td align="left" rowspan="1" colspan="1">1. Introduction of IMGT gaps</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"><bold><italic>Applications:</italic></bold> IMGT antibody engineering and humanization for V and C.</td>
                <td align="left" rowspan="1" colspan="1">2. Identification of the closest genes and alleles (germline V and J for V-DOMAIN)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">3. Delimitation of the domains</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">4. Description of AA changes</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">5. IMGT Colliers de Perles (<xref rid="B53" ref-type="bibr">53</xref>–<xref rid="B57" ref-type="bibr">57</xref>) with highlighted AA changes (pink circles online).</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN001">
              <p><sup>a</sup>V: V domain (includes V-DOMAIN of IG and TR and V-LIKE-DOMAIN of IgSF other than IG and TR) (<xref rid="B48" ref-type="bibr">48</xref>,<xref rid="B49" ref-type="bibr">49</xref>).</p>
            </fn>
            <fn id="TFN002">
              <p>C: C domain (includes C-DOMAIN of IG and TR and C-LIKE-DOMAIN of IgSF other than IG and TR) (<xref rid="B50" ref-type="bibr">50</xref>).</p>
            </fn>
            <fn id="TFN003">
              <p>G: G domain (includes G-DOMAIN of MH and G-LIKE-DOMAIN of MhSF other than MH) (<xref rid="B51" ref-type="bibr">51</xref>).</p>
            </fn>
            <fn id="TFN004">
              <p><sup>b</sup>in September 2014, more than 4 billions of sequences analyzed by IMGT/HighV-QUEST, by 943 users from 40 countries (45% users from USA, 36% from EU, 19% from the remaining world).</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>The IMGT/V-QUEST reference directories have been set up for species which have been extensively studied, such as human and mouse. This also holds for the other species or taxons with incomplete IMGT reference directory sets. In those cases, results should be interpreted considering the status of the IMGT reference directory (information on the updates on the IMGT<sup>®</sup> web site). Links to the IMGT/V-QUEST reference directory sets are available from the IMGT/V-QUEST Welcome page (<xref rid="B13" ref-type="bibr">13</xref>–<xref rid="B18" ref-type="bibr">18</xref>).</p>
        <p>The analysis of the junctions of the rearranged V-J and V-D-J sequences of the IG and TR variable domains (<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>) is performed by the IMGT/JunctionAnalysis tool (<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B20" ref-type="bibr">20</xref>) which is integrated in IMGT/V-QUEST and IMGT/HighV-QUEST. This tool provides a detailed analysis by delimiting very precisely the different regions that participate to the junction. To answer this higher-resolution analysis, additional labels (3′V-REGION, 5′J-REGION) and corresponding reference directory sets had to be created.</p>
      </sec>
      <sec id="SEC3-1-2">
        <title>IMGT/DomainSeq reference directory</title>
        <p>IMGT/Domain GapAlign (<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>) analyses AA sequences of the V, C and G domains. This tool run against the IMGT/DomainSeq reference directory database (Table <xref rid="tbl1" ref-type="table">1</xref>) that include sets for the V, C and G domains. These sets comprise sequences from the IMGT Repertoire (<xref rid="B1" ref-type="bibr">1</xref>) and from IMGT/GENE-DB (<xref rid="B8" ref-type="bibr">8</xref>). Owing to the particularities of the IG and TR V-DOMAIN synthesis (<xref rid="B3" ref-type="bibr">3</xref>,<xref rid="B4" ref-type="bibr">4</xref>) there is no V-DOMAIN in the IMGT/DomainSeq reference directory. Instead, the directory comprises the translation of the IG and TR germline V and J genes (V-REGION and J-REGION, respectively). The IMGT/DomainSeq reference directory provides the IMGT<sup>®</sup> ‘gene’ and ‘allele’ names. Data are comprehensive for human and mouse IG and TR, whereas for other species and other IgSF and MhSF they are added progressively. The IMGT/DomainSeq reference directory comprises domain sequences of functional (F), ORF and in-frame pseudogene (P) genes. As IMGT<sup>®</sup> alleles are characterized at the nucleotide level, identical sequences at the AA level may therefore correspond to different alleles, in the IMGT/DomainSeq reference directory. The sequences of the IMGT/DomainSeq reference directory sets can be displayed by querying IMGT/DomainDisplay (<ext-link xlink:href="http://www.imgt.org" ext-link-type="uri">http://www.imgt.org</ext-link>).</p>
      </sec>
    </sec>
    <sec id="SEC3-2">
      <title>IMGT structure databases</title>
      <sec id="SEC3-2-1">
        <title>IMGT/3Dstructure-DB</title>
        <p>IMGT/3Dstructure-DB (<xref rid="B9" ref-type="bibr">9</xref>–<xref rid="B11" ref-type="bibr">11</xref>), the IMGT<sup>®</sup> structure database, provides IMGT<sup>®</sup> annotation and contact analysis of IG, TR, MH, IgSF and MhSF 3D structures, and paratope/epitope description of IG/antigen (<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B35" ref-type="bibr">35</xref>,<xref rid="B63" ref-type="bibr">63</xref>–<xref rid="B66" ref-type="bibr">66</xref>) and TR/pMH (<xref rid="B67" ref-type="bibr">67,68</xref>) complexes (Table <xref rid="tbl2" ref-type="table">2</xref>). There is one ‘IMGT/3Dstructure-DB card’ per IMGT/3Dstructure-DB entry and this card provides access to all data related to that entry. The ‘Protein Data Bank (PDB) code’ (4 letters and/or numbers, e.g. 1n0x) is used as ‘IMGT entry ID’ for the 3D structures obtained from the Research Collaboratory for Structural Bioinformatics PDB (<xref rid="B69" ref-type="bibr">69</xref>)<bold>.</bold> The IMGT/3Dstructure-DB card provides eight search/display options: ‘Chain details’, ‘Contact analysis’, ‘Paratope and epitope’, ‘3D visualization Jmol or QuickPDB’, ‘Renumbered IMGT files’, ‘IMGT numbering comparison’, ‘References and links’, ‘Printable card’ (<xref rid="B9" ref-type="bibr">9</xref>–<xref rid="B11" ref-type="bibr">11</xref>).</p>
        <table-wrap position="float" id="tbl2">
          <label>Table 2.</label>
          <caption>
            <title>IMGT<sup>®</sup> structure databases and associated tool functionalities/results</title>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">IMGT<sup>®</sup> structure databases</th>
                <th align="left" rowspan="1" colspan="1">Content and examples of applications</th>
                <th align="left" rowspan="1" colspan="1">Tool functionalities/results (including those for V, C of G domains<sup>a</sup>)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">IMGT/3Dstructure-DB (<xref rid="B9" ref-type="bibr">9</xref>–<xref rid="B11" ref-type="bibr">11</xref>)</td>
                <td align="left" rowspan="1" colspan="1">3128 structure entries of which 2053 IG (including 1315 IG/Ag complexes), 240 TR and 712 MH (including 143 TR/pMH complexes: 108 TR/pMH1 + 35 TR/pMH2) (September 2014).</td>
                <td align="left" rowspan="1" colspan="1">1. Identification of the closest genes and alleles (germline V and J genes and alleles for V-DOMAIN)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"><bold><italic>Applications:</italic></bold> identification of the paratope and epitope in IG/AG and TR/pMH complexes and pMH contacts.</td>
                <td align="left" rowspan="1" colspan="1">2. IMGT/DomainGapAlign results (<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">3. IMGT Collier de Perles (<xref rid="B53" ref-type="bibr">53</xref>–<xref rid="B57" ref-type="bibr">57</xref>) (on two layers with hydrogen bonds for V and C domains or with pMH contact sites for G-DOMAIN)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">4. Contact analysis between a pair of domains or between a domain and a ligand</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">5. Renumbered IMGT files</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">6. IMGT numbering comparison</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">IMGT/2Dstructure-DB (<xref rid="B11" ref-type="bibr">11</xref>)*</td>
                <td align="left" rowspan="1" colspan="1">561 AA sequence entries (225 INN + 336 Kabat) of which 548 IG (212 INN + 336 Kabat) (September 2014)*</td>
                <td align="left" rowspan="1" colspan="1">1. Identification of the closest genes and alleles (germline V and J genes and alleles for V-DOMAIN)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"><bold><italic>Applications:</italic></bold> from gene to structures in the absence of 3D.</td>
                <td align="left" rowspan="1" colspan="1">2. IMGT/DomainGapAlign results (<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">3. IMGT Collier de Perles (<xref rid="B53" ref-type="bibr">53</xref>–<xref rid="B57" ref-type="bibr">57</xref>)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1"/>
                <td align="left" rowspan="1" colspan="1">4. Renumbered IMGT files</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="TFN005">
              <p>An asterisk (*) indicates that parts of the protocol dealing with 3D structures (hydrogen bonds in IMGT Colliers de Perles on two layers, Contact analysis) are not relevant, otherwise all other queries and results are similar to IMGT/3Dstructure-DB.</p>
            </fn>
            <fn id="TFN006">
              <p><sup>a</sup>V: V domain (includes V-DOMAIN of IG and TR and V-LIKE-DOMAIN of IgSF other than IG and TR) (<xref rid="B48" ref-type="bibr">48</xref>,<xref rid="B49" ref-type="bibr">49</xref>).</p>
            </fn>
            <fn id="TFN007">
              <p>C: C domain (includes C-DOMAIN of IG and TR and C-LIKE-DOMAIN of IgSF other than IG and TR) (<xref rid="B50" ref-type="bibr">50</xref>).</p>
            </fn>
            <fn id="TFN008">
              <p>G: G domain (includes G-DOMAIN of MH and G-LIKE-DOMAIN of MhSF other than MH) (<xref rid="B51" ref-type="bibr">51</xref>).</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>The ‘Chain details’ section comprises information first on the chain itself, then per domain (<xref rid="B9" ref-type="bibr">9</xref>–<xref rid="B11" ref-type="bibr">11</xref>). Chain and domain annotation includes the IMGT gene and allele names (CLASSIFICATION), region and domain delimitations (DESCRIPTION) and domain AA positions according to the IMGT unique numbering (NUMEROTATION) (<xref rid="B47" ref-type="bibr">47</xref>–<xref rid="B52" ref-type="bibr">52</xref>). The closest IMGT<sup>®</sup> genes and alleles (found expressed in each domain of a chain) are identified with the integrated IMGT/DomainGapAlign (<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref>), which aligns the AA sequences of the 3D structures with the IMGT/DomainSeq reference directory.</p>
        <p>‘Contact analysis’ gives access to a table with the different ‘Domain pair contacts’ of the 3D structure (this table is also accessed from ‘Chain details’ by clicking on ‘Domain contact (overview)’). ‘Domain pair contacts’ refer to contacts between a pair of domains or between a domain and a ligand. Clicking on ‘DomPair’ gives access to the contacts between AA for a given ‘Domain pair contacts’. For IG/Ag (<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B35" ref-type="bibr">35</xref>,<xref rid="B63" ref-type="bibr">63</xref>–<xref rid="B66" ref-type="bibr">66</xref>) and TR/pMH (<xref rid="B67" ref-type="bibr">67</xref>,<xref rid="B68" ref-type="bibr">68</xref>) complexes, the paratope and epitope are displayed in Contact analysis, but for each V domain, separately.</p>
        <p>‘Renumbered IMGT file’ allows to view (or download) an IMGT coordinate file renumbered according to the IMGT unique numbering, and with added IMGT specific information on chains and domains (added in the ‘REMARK 410′ lines (blue online), and identical to the ‘Chain details’ annotation). ‘IMGT numbering comparison’ provides, per domain, the IMGT DOMAIN numbering by comparison with the PDB numbering, and the residue (3-letter and 1-letter names), which allows standardized IMGT representations using generic tools.</p>
      </sec>
      <sec id="SEC3-2-2">
        <title>IMGT/2Dstructure-DB</title>
        <p>IMGT/2Dstructure-DB was created as an extension of IMGT/3Dstructure-DB (<xref rid="B9" ref-type="bibr">9</xref>–<xref rid="B11" ref-type="bibr">11</xref>) to describe and analyse AA sequences of chains and domains for which no 3D structures were available (Table <xref rid="tbl2" ref-type="table">2</xref>). IMGT/2Dstructure-DB uses the IMGT/3Dstructure-DB informatics frame and interface which allow one to analyse, manage and query IG, TR and MH, as well as other IgSF and MhSF and engineered proteins (FPIA, composite proteins for clinical applications (CPCA)), as polymeric receptors made of several chains, in contrast to the IMGT/LIGM-DB sequence database that analyses and manages sequences individually (<xref rid="B7" ref-type="bibr">7</xref>). The AA sequences are analysed with the IMGT<sup>®</sup> criteria of standardized identification (<xref rid="B44" ref-type="bibr">44</xref>), description (<xref rid="B45" ref-type="bibr">45</xref>), nomenclature (<xref rid="B46" ref-type="bibr">46</xref>) and numerotation (<xref rid="B47" ref-type="bibr">47</xref>–<xref rid="B52" ref-type="bibr">52</xref>).</p>
        <p>The current IMGT/2Dstructure-DB entries include AA sequences of antibodies from Kabat (<xref rid="B70" ref-type="bibr">70</xref>) (those for which there were no available nucleotide sequences), and AA sequences of mAb and FPIA from the WHO-INN programme (<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B39" ref-type="bibr">39</xref>,<xref rid="B40" ref-type="bibr">40</xref>). Queries can be made on an individual entry, using the Entry ID or the Molecule name. The same query interface is used for IMGT/2Dstructure-DB and IMGT/3Dstructure-DB. Thus a ‘trastuzumab’ query in ‘Molecule name’ allows to retrieve three results: two INN (‘trastuzumab’ and ‘trastuzumab emtansine’) from IMGT/2Dstructure-DB, and one 3D structure (‘1nz8′) from IMGT/3Dstructure-DB.</p>
        <p>The IMGT/2Dstructure-DB cards provide standardized IMGT information on chains and domains and IMGT Colliers de Perles on one or two layers, identical to that provided for the sequence analysis in IMGT/3Dstructure-DB, however, the information on experimental structural data (hydrogen bonds in IMGT Collier de Perles on two layers, Contact analysis) is only available in the corresponding IMGT/3Dstructure-DB cards, if the antibodies have been crystallized.</p>
      </sec>
      <sec id="SEC3-2-3">
        <title>IMGT/mAb-DB</title>
        <p>A new database and interface, IMGT/mAb-DB (<xref rid="B12" ref-type="bibr">12</xref>), <ext-link xlink:href="http://www.imgt.org" ext-link-type="uri">http://www.imgt.org</ext-link>, has been developed to provide an easy access to therapeutic antibody AA sequences (links to IMGT/2Dstructure-DB) and structures (links to IMGT/3Dstructure-DB, if 3D structures are available) (Figure <xref rid="F2" ref-type="fig">2</xref>). IMGT/mAb-DB data include monoclonal antibodies (mAb, INN suffix –mab) (a –mab is defined by the presence of at least an IG variable domain) and fusion proteins for immune applications (FPIA, INN suffix –cept) (a –cept is defined by a receptor fused to a Fc) from the WHO-INN programme (<xref rid="B39" ref-type="bibr">39</xref>,<xref rid="B40" ref-type="bibr">40</xref>). This database also includes a few CPCA (e.g. protein or peptide fused to a Fc for only increasing their half-life, identified by the INN prefix ef–) and some RPI used, unmodified, for clinical applications.</p>
        <fig position="float" id="F2">
          <label>Figure 2.</label>
          <caption>
            <p>IMGT/mAb-DB, <ext-link xlink:href="http://www.imgt.org" ext-link-type="uri">http://www.imgt.org</ext-link>. The part of the results for two entries is shown with the links to IMGT/2Dstructure-DB and IMGT/3Dstructure-DB, respectively.</p>
          </caption>
          <graphic xlink:href="gku1056fig2" position="float"/>
        </fig>
      </sec>
    </sec>
  </sec>
  <sec id="SEC4">
    <title>FUTURE DIRECTIONS</title>
    <p>IMGT-ONTOLOGY and the IMGT<sup>®</sup> information system, which are at the origin of immunoinformatics, have provided the concepts, the knowledge environment and the informatics frame for a standardized and integrated analysis of IG, TR and MH, extended to other IgSF and MhSF, from gene to structure and function (<xref rid="B2" ref-type="bibr">2</xref>). IG and TR repertoire and clonality analysis, NGS repertoire in normal immune responses (vaccination, cancers, infections) and in abnormal responses (autoimmune diseases), clonotype specificity, antibody humanization, IG and TR engineering for immunotherapy, IG allotypes and immunogenicity, paratope/epitope characterization and specificity represent major current fields of immunoinformatics at the forefront of basic, clinical and pharmaceutical research owing to major methodological advances and medical implications.</p>
    <p>The IMGT<sup>®</sup> databases and tools, and implicitly IMGT<sup>®</sup> reference directories, are widely used in clinical applications. Thus, IMGT/V-QUEST is frequently used by clinicians for the analysis of IG somatic hypermutations in leukemia, lymphoma and myeloma, and more particularly in chronic lymphocytic leukemia (CLL) (<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B71" ref-type="bibr">71</xref>) in which the percentage of mutations of the rearranged IGHV gene in the VH of the leukemic clone has a prognostic value for the patients. For this evaluation, IMGT/V-QUEST is the standard recommended by the European Research Initiative on CLL for comparative analysis between laboratories (<xref rid="B71" ref-type="bibr">71</xref>). The sequences of the V-(D)-J junctions determined by IMGT/JunctionAnalysis (<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B20" ref-type="bibr">20</xref>) are also used in the characterization of stereotypic patterns in CLL and for the synthesis of probes specific of the junction for the detection and follow-up of minimal residual diseases (MRD) in leukemias and lymphomas. A new era is opening in hemato-oncology with the use of NGS for analysis of the clonality and MRD identification, making IMGT<sup>®</sup> standards use more needed as ever. More generally, the IMGT/HighV-QUEST web portal is a paradigm for identification of IMGT clonotype diversity and expression in NGS immune repertoire analysis of the adaptive immune response in infectious diseases, in vaccination and for next generation repertoire immunoprofiling (<xref rid="B24" ref-type="bibr">24</xref>). The IMGT<sup>®</sup> reference directory databases behind these tools are key to provide standardized results.</p>
    <p>The therapeutic monoclonal antibody engineering field represents the most promising potential in medicine (<xref rid="B64" ref-type="bibr">64</xref>). A standardized analysis of IG genomic and expressed sequences, structures and interactions is crucial for a better molecular understanding and comparison of the mAb specificity, affinity, half-life, Fc effector properties and potential immunogenicity. IMGT-ONTOLOGY concepts have become a necessity for IG loci description of newly sequenced genomes, antibody structure/function characterization, allotypes in relation with molecular and structural analysis (<xref rid="B72" ref-type="bibr">72</xref>–<xref rid="B74" ref-type="bibr">74</xref>), antibody engineering (single chain Fragment variable (scFv), phage displays, combinatorial libraries) and antibody humanization (chimeric, humanized and human antibodies) (<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B35" ref-type="bibr">35</xref>,<xref rid="B63" ref-type="bibr">63</xref>–<xref rid="B66" ref-type="bibr">66</xref>). IMGT<sup>®</sup> standardization allows repertoire analysis and antibody humanization studies to move to novel high-throughput methodologies with the same high-quality criteria. The CDR-IMGT lengths are now required for mAb INN applications and are included in the WHO-INN definitions (<xref rid="B40" ref-type="bibr">40</xref>), bringing a new level of standardized information in the comparative analysis of therapeutic antibodies.</p>
  </sec>
  <sec id="SEC5">
    <title>CITING IMGT</title>
    <p>Users are requested to cite this article and quote the IMGT Home page URL, <ext-link xlink:href="http://www.imgt.org" ext-link-type="uri">http://www.imgt.org</ext-link>.</p>
  </sec>
</body>
<back>
  <ack>
    <p>We are grateful to all the previous members of the IMGT<sup>®</sup> team, for their expertise and constant motivation. We thank Cold Spring Harbor Protocol Press for the pdf of the IMGT Booklet available in IMGT references. IMGT<sup>®</sup> is a registered trademark of CNRS. IMGT<sup>®</sup> is member of the International Medical Informatics Association (IMIA).</p>
  </ack>
  <fn-group>
    <fn id="FN1" fn-type="present-address">
      <p>Present address: Marie-Paule Lefranc, IMGT<sup>®</sup>, the international ImMunoGeneTics information system<sup>®</sup>, Université de Montpellier, Laboratoire d'ImmunoGénétique Moléculaire LIGM, UPR CNRS 1142, Institut de Génétique Humaine, 141 rue de la Cardonille, Montpellier, 34396 cedex 5, France.</p>
    </fn>
  </fn-group>
  <sec id="SEC6">
    <title>FUNDING</title>
    <p>IMGT<sup>®</sup> was funded in part by programmes of the European Union (EU): BIOMED1 [BIOCT930038]; Biotechnology BIOTECH2 [BIO4CT960037]; 5th PCRDT Quality of Life and Management of Living Resources [QLG2–2000–01287]; 6th PCRDT Information Science and Technology [ImmunoGrid, FP6 IST-028069]. IMGT<sup>®</sup> is currently supported by the Centre National de la Recherche Scientifique (CNRS); the Ministère de l'Enseignement Supérieur et de la Recherche (MESR); the Université de Montpellier, France; the Agence Nationale de la Recherche (ANR) Labex MabImprove [ANR-10-LABX-53–01]; BioCampus Montpellier; Région Languedoc-Roussillon (Grand Plateau Technique pour la Recherche (GPTR)). This work was granted access to the HPC resources of CINES under the allocation [036029] (2010–2014) made by GENCI (Grand Equipement National de Calcul Intensif). Funding for open access charge: IMGT (Université de Montpellier and CNRS).</p>
    <p><italic>Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Ginestoux</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Jabado-Michaloud</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Folch</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Bellahcene</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Gemrot</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Brochet</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Lane</surname>
            <given-names>J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>IMGT®, the international ImMunoGeneTics information system®</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2009</year>
        <volume>37</volume>
        <fpage>D1006</fpage>
        <lpage>D1012</lpage>
        <pub-id pub-id-type="pmid">18978023</pub-id>
      </element-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M-P.</given-names>
          </name>
        </person-group>
        <article-title>Immunoglobulin (IG) and T cell receptor genes (TR): IMGT® and the birth and rise of immunoinformatics</article-title>
        <source>Front Immunol.</source>
        <year>2014</year>
        <volume>5</volume>
        <fpage>1</fpage>
        <lpage>22</lpage>
        <pub-id pub-id-type="pmid">24474949</pub-id>
      </element-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>G.</given-names>
          </name>
        </person-group>
        <source>The Immunoglobulin FactsBook</source>
        <year>2001</year>
        <publisher-loc>London</publisher-loc>
        <publisher-name>Academic Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>G.</given-names>
          </name>
        </person-group>
        <source>The T cell receptor FactsBook</source>
        <year>2001</year>
        <publisher-loc>London</publisher-loc>
        <publisher-name>Academic Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Coligan</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Bierer</surname>
            <given-names>BE</given-names>
          </name>
          <name>
            <surname>Margulies</surname>
            <given-names>DE</given-names>
          </name>
          <name>
            <surname>Shevach</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Strober</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Nomenclature of the human immunoglobulin genes</article-title>
        <source>Current Protocols in Immunology, A.1P.1-A.1P.37</source>
        <year>2000</year>
        <publisher-loc>Hoboken, NJ</publisher-loc>
        <publisher-name>John Wiley and Sons</publisher-name>
        <fpage>1</fpage>
        <lpage>37</lpage>
      </element-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Coligan</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Bierer</surname>
            <given-names>BE</given-names>
          </name>
          <name>
            <surname>Margulies</surname>
            <given-names>DE</given-names>
          </name>
          <name>
            <surname>Shevach</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Strober</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Nomenclature of the human T cell Receptor genes</article-title>
        <source>Current Protocols in Immunology, A.1O.1-A.1O.23</source>
        <year>2000</year>
        <publisher-loc>Hoboken, NJ</publisher-loc>
        <publisher-name>John Wiley and Sons</publisher-name>
        <fpage>1</fpage>
        <lpage>23</lpage>
      </element-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Duroux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Ginestoux</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Folch</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Jabado-Michaloud</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Chaume</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/LIGM-DB, the IMGT® comprehensive database of immunoglobulin and T cell receptor nucleotide sequences</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2006</year>
        <volume>34</volume>
        <fpage>D781</fpage>
        <lpage>D784</lpage>
        <pub-id pub-id-type="pmid">16381979</pub-id>
      </element-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Chaume</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2005</year>
        <volume>33</volume>
        <fpage>D256</fpage>
        <lpage>D261</lpage>
        <pub-id pub-id-type="pmid">15608191</pub-id>
      </element-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kaas</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Ruiz</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/3Dstructure-DB and IMGT/StructuralQuery, a database and a tool for immunoglobulin, T cell receptor and MHC structural data</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2004</year>
        <volume>32</volume>
        <fpage>D208</fpage>
        <lpage>D210</lpage>
        <pub-id pub-id-type="pmid">14681396</pub-id>
      </element-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ehrenmann</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Kaas</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2010</year>
        <volume>38</volume>
        <fpage>D301</fpage>
        <lpage>D307</lpage>
        <pub-id pub-id-type="pmid">19900967</pub-id>
      </element-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ehrenmann</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/3Dstructure-DB: querying the IMGT database for 3D structures in immunology and immunoinformatics (IG or antibodies, TR, MH, RPI, and FPIA)</article-title>
        <source>Cold Spring Harbor Protoc.</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>750</fpage>
        <lpage>761</lpage>
      </element-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Poiron</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Ginestoux</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Ehrenmann</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Duroux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/mAb-DB: the IMGT® database for therapeutic monoclonal antibodies</article-title>
        <source>11<sup>èmes</sup> Journées Ouvertes de Biologie, Informatique et Mathématiques (JOBIM), Montpellier</source>
        <year>2010</year>
        <comment>7–9 September 2010, <ext-link xlink:href="http://www.jobim2010.fr/indexe662.html?q=en/node/56" ext-link-type="uri">http://www.jobim2010.fr/indexe662.html?q=en/node/56</ext-link></comment>
      </element-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Chaume</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/V-QUEST, an integrated software for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2004</year>
        <volume>32</volume>
        <fpage>W435</fpage>
        <lpage>W440</lpage>
        <pub-id pub-id-type="pmid">15215425</pub-id>
      </element-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Veskler</surname>
            <given-names>BA</given-names>
          </name>
        </person-group>
        <article-title>Interactive IMGT on-line tools for the analysis of immunoglobulin and T cell receptor repertoires</article-title>
        <source>New Research on Immunology</source>
        <year>2005</year>
        <publisher-loc>NY</publisher-loc>
        <publisher-name>Nova Science Publishers Inc</publisher-name>
        <fpage>77</fpage>
        <lpage>105</lpage>
      </element-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brochet</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2008</year>
        <volume>36</volume>
        <fpage>W503</fpage>
        <lpage>W508</lpage>
        <pub-id pub-id-type="pmid">18503082</pub-id>
      </element-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Ghia</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Rosenquist</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Davi</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>IMGT® standardized analysis of immunoglobulin rearranged sequences</article-title>
        <source>Immunoglobulin Gene Analysis in Chronic Lymphocytic Leukemia</source>
        <year>2008</year>
        <publisher-loc>Italy</publisher-loc>
        <publisher-name>Wolters Kluwer Health Italy</publisher-name>
        <fpage>33</fpage>
        <lpage>52</lpage>
      </element-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Brochet</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences</article-title>
        <source>Cold Spring Harbor Protoc</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>695</fpage>
        <lpage>715</lpage>
      </element-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Alamyar</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Duroux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Christiansen</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Tait</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>IMGT® tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS</article-title>
        <source>Immunogenetics</source>
        <year>2012</year>
        <volume>882</volume>
        <publisher-loc>Springer, NY</publisher-loc>
        <publisher-name>Humana Press</publisher-name>
        <fpage>569</fpage>
        <lpage>604</lpage>
      </element-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yousfi Monod</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Chaume</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs</article-title>
        <source>Bioinformatics</source>
        <year>2004</year>
        <volume>20</volume>
        <fpage>i379</fpage>
        <lpage>i385</lpage>
        <pub-id pub-id-type="pmid">15262823</pub-id>
      </element-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/JunctionAnalysis: IMGT standardized analysis of the V-J and V-D-J junctions of the rearranged immunoglobulins (IG) and T cell receptors (TR)</article-title>
        <source>Cold Spring Harbor Protoc.</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>716</fpage>
        <lpage>725</lpage>
      </element-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Protat</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>The IMGT strategy for the automatic annotation of IG and TR cDNA sequences: IMGT/Automat</article-title>
        <source>Proceedings of the European Conference on Computational Biology (ECCB 2003), Data and Knowledge Bases, Poster DKB_31</source>
        <year>2003</year>
        <publisher-loc>Paris</publisher-loc>
        <publisher-name>Institut National de Recherche en Informatique et en Automatique, Paris, ECCB 2003, September 27–30</publisher-name>
        <fpage>103</fpage>
        <lpage>104</lpage>
      </element-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Chaume</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Jabado-Michaloud</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>Immunogenetics sequence annotation: the strategy of IMGT based on IMGT-ONTOLOGY</article-title>
        <source>Stud. Health Technol. Inform.</source>
        <year>2005</year>
        <volume>116</volume>
        <fpage>3</fpage>
        <lpage>8</lpage>
        <pub-id pub-id-type="pmid">16160227</pub-id>
      </element-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Alamyar</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Shuo</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Duroux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/HighV-QUEST: the IMGT® web portal for immunoglobulin (IG) or antibody and T cell receptor (TR) analysis from NGS high throughput and deep sequencing</article-title>
        <source>Immunome Res.</source>
        <year>2012</year>
        <volume>8</volume>
        <fpage>1</fpage>
        <lpage>26</lpage>
      </element-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
          <name>
            <surname>Miles</surname>
            <given-names>J.J.</given-names>
          </name>
          <name>
            <surname>Alamyar</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Duroux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Freeman</surname>
            <given-names>J.D.</given-names>
          </name>
          <name>
            <surname>Corbin</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Scheerlinck</surname>
            <given-names>J.-P.</given-names>
          </name>
          <name>
            <surname>Frohman</surname>
            <given-names>M.A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>IMGT/HighV-QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling</article-title>
        <source>Nature Comm.</source>
        <year>2013</year>
        <volume>4</volume>
        <fpage>1</fpage>
        <lpage>13</lpage>
      </element-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ehrenmann</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/DomainGapAlign: IMGT standardized analysis of amino acid sequences of Variable, Constant, and Groove Domains (IG, TR, MH, IgSF, MhSF)</article-title>
        <source>Cold Spring Harbor Protoc.</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>737</fpage>
        <lpage>749</lpage>
      </element-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Ehrenmann</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Christiansen</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Tait</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>IMGT/DomainGapAlign: the IMGT® tool for the analysis of IG, TR, MHC, IgSF and MhcSF domain amino acid polymorphism</article-title>
        <source>Immunogenetics</source>
        <year>2012</year>
        <volume>882</volume>
        <publisher-loc>Springer, NY</publisher-loc>
        <publisher-name>Humana Press</publisher-name>
        <fpage>605</fpage>
        <lpage>633</lpage>
      </element-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ehrenmann</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Duroux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT/Collier de Perles: IMGT standardized representation of domains (IG, TR, and IgSF Variable and Constant domains, MH and MhSF Groove domains)</article-title>
        <source>Cold Spring Harbor Protoc.</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>726</fpage>
        <lpage>736</lpage>
      </element-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lane</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Duroux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>From IMGT-ONTOLOGY to IMGT/LIGMotif: the IMGT® standardized approach for immunoglobulin and T cell receptor gene identification and description in large genomic sequences</article-title>
        <source>BMC Bioinformat.</source>
        <year>2010</year>
        <volume>11</volume>
        <fpage>1</fpage>
        <lpage>16</lpage>
      </element-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pommié</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Levadoux</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Sabatier</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties</article-title>
        <source>J. Mol. Recognit.</source>
        <year>2004</year>
        <volume>17</volume>
        <fpage>17</fpage>
        <lpage>32</lpage>
        <pub-id pub-id-type="pmid">14872534</pub-id>
      </element-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Lo</surname>
            <given-names>BKC</given-names>
          </name>
        </person-group>
        <article-title>IMGT, the international ImMunoGenetics information system®</article-title>
        <source>Antibody Engineering Methods and Protocols</source>
        <year>2004</year>
        <volume>248</volume>
        <edition>2nd edn</edition>
        <publisher-loc>Totowa, NJ</publisher-loc>
        <publisher-name>Humana Press</publisher-name>
        <fpage>27</fpage>
        <lpage>49</lpage>
      </element-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Regnier</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Duroux</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT®, a system and an ontology that bridge biological and computational spheres in bioinformatics</article-title>
        <source>Brief. Bioinform.</source>
        <year>2008</year>
        <volume>9</volume>
        <fpage>263</fpage>
        <lpage>275</lpage>
        <pub-id pub-id-type="pmid">18424816</pub-id>
      </element-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>An</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Antibody databases and tools: the IMGT® experience</article-title>
        <source>Therapeutic Monoclonal Antibodies: From Bench to Clinic</source>
        <year>2009</year>
        <publisher-loc>Hoboken, NJ</publisher-loc>
        <publisher-name>John Wiley and Sons</publisher-name>
        <fpage>91</fpage>
        <lpage>114</lpage>
      </element-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Ehrenmann</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Duroux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Kontermann</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Dübel</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Standardized sequence and structure analysis of antibody using IMGT®</article-title>
        <source>Antibody Engineering</source>
        <year>2010</year>
        <volume>2</volume>
        <publisher-loc>Heidelberg, Berlin</publisher-loc>
        <publisher-name>Springer-Verlab</publisher-name>
        <fpage>11</fpage>
        <lpage>31</lpage>
      </element-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT, the International ImMunoGeneTics Information System</article-title>
        <source>Cold Spring Harbor Protoc.</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>595</fpage>
        <lpage>603</lpage>
      </element-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
          <name>
            <surname>Ehrenmann</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Ginestoux</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Duroux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Chames</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Use of IMGT® databases and tools for antibody engineering and humanization</article-title>
        <source>Antibody Engineering</source>
        <year>2012</year>
        <volume>907</volume>
        <publisher-loc>Springer, NY</publisher-loc>
        <publisher-name>Humana Press</publisher-name>
        <fpage>3</fpage>
        <lpage>37</lpage>
      </element-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Dubitzky</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wolkenhauer</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Cho</surname>
            <given-names>K-H</given-names>
          </name>
          <name>
            <surname>Yokota</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>IMGT® Information System</article-title>
        <source>Encyclopedia of Systems Biology</source>
        <year>2013</year>
        <publisher-loc>NY</publisher-loc>
        <publisher-name>Springer Science+Business Media, LLC012</publisher-name>
        <fpage>959</fpage>
        <lpage>964</lpage>
      </element-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>WHO-IUIS Nomenclature Subcommittee for immunoglobulins and T cell receptors report</article-title>
        <source>Immunogenetics</source>
        <year>2007</year>
        <volume>59</volume>
        <fpage>899</fpage>
        <lpage>902</lpage>
        <pub-id pub-id-type="pmid">18046549</pub-id>
      </element-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>WHO-IUIS Nomenclature Subcommittee for immunoglobulins and T cell receptors report August 2007, 13th International Congress of Immunology, Rio de Janeiro, Brazil</article-title>
        <source>Dev. Comp. Immunol.</source>
        <year>2008</year>
        <volume>32</volume>
        <fpage>461</fpage>
        <lpage>463</lpage>
        <pub-id pub-id-type="pmid">18036660</pub-id>
      </element-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <element-citation publication-type="book">
        <collab>World Health Organization</collab>
        <source>International Nonproprietary Names (INN) for Biological and Biotechnological Substances (A Review). INN Working Document 05.179. Update 2012</source>
        <year>2012</year>
        <publisher-loc>Geneva</publisher-loc>
        <publisher-name>WHO Press</publisher-name>
      </element-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M-P.</given-names>
          </name>
        </person-group>
        <article-title>Antibody nomenclature: from IMGT-ONTOLOGY to INN definition</article-title>
        <source>MABS</source>
        <year>2011</year>
        <volume>3</volume>
        <fpage>1</fpage>
        <lpage>2</lpage>
        <pub-id pub-id-type="pmid">21099347</pub-id>
      </element-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>Ontology for immunogenetics: IMGT-ONTOLOGY</article-title>
        <source>Bioinformatics</source>
        <year>1999</year>
        <volume>15</volume>
        <fpage>1047</fpage>
        <lpage>1054</lpage>
        <pub-id pub-id-type="pmid">10745995</pub-id>
      </element-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT-ONTOLOGY 2012. Frontiers in bioinformatics and computational biology</article-title>
        <source>Front. Genet.</source>
        <year>2012</year>
        <volume>3</volume>
        <fpage>1</fpage>
        <lpage>16</lpage>
        <pub-id pub-id-type="pmid">22303408</pub-id>
      </element-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Dubitzky</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wolkenhauer</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Cho</surname>
            <given-names>K-H</given-names>
          </name>
          <name>
            <surname>Yokota</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>IMGT-ONTOLOGY</article-title>
        <source>Encyclopedia of Systems Biology</source>
        <year>2013</year>
        <publisher-loc>NY</publisher-loc>
        <publisher-name>Springer Science+Business Media, LLC012</publisher-name>
        <fpage>964</fpage>
        <lpage>972</lpage>
      </element-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M-P.</given-names>
          </name>
        </person-group>
        <article-title>From IMGT-ONTOLOGY IDENTIFICATION axiom to IMGT standardized keywords: for immunoglobulins (IG), T cell receptors (TR), and conventional genes</article-title>
        <source>Cold Spring Harbor Protoc.</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>604</fpage>
        <lpage>613</lpage>
      </element-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M-P.</given-names>
          </name>
        </person-group>
        <article-title>From IMGT-ONTOLOGY DESCRIPTION axiom to IMGT standardized labels: for immunoglobulin (IG) and T cell receptor (TR) sequences and structures</article-title>
        <source>Cold Spring Harbor Protoc.</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>614</fpage>
        <lpage>626</lpage>
      </element-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M-P.</given-names>
          </name>
        </person-group>
        <article-title>From IMGT-ONTOLOGY CLASSIFICATION axiom to IMGT standardized gene and allele nomenclature: for immunoglobulins (IG) and T cell receptors (TR)</article-title>
        <source>Cold Spring Harb Protoc.</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>627</fpage>
        <lpage>632</lpage>
      </element-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>Unique database numbering system for immunogenetic analysis</article-title>
        <source>Immunol. Today.</source>
        <year>1997</year>
        <volume>18</volume>
        <fpage>509</fpage>
        <pub-id pub-id-type="pmid">9386342</pub-id>
      </element-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>The IMGT unique numbering for Immunoglobulins, T cell receptors and Ig-like domains</article-title>
        <source>Immunol.</source>
        <year>1999</year>
        <volume>7</volume>
        <fpage>132</fpage>
        <lpage>136</lpage>
      </element-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
          <name>
            <surname>Pommié</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Ruiz</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Foulquier</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Truong</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Thouvenin-Contet</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>G.</given-names>
          </name>
        </person-group>
        <article-title>IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains</article-title>
        <source>Dev. Comp. Immunol.</source>
        <year>2003</year>
        <volume>27</volume>
        <fpage>55</fpage>
        <lpage>77</lpage>
        <pub-id pub-id-type="pmid">12477501</pub-id>
      </element-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
          <name>
            <surname>Pommié</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Kaas</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Duprat</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Bosc</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Guiraudou</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Jean</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Ruiz</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Da Piedade</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Rouard</surname>
            <given-names>M.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains</article-title>
        <source>Dev. Comp. Immunol.</source>
        <year>2005</year>
        <volume>29</volume>
        <fpage>185</fpage>
        <lpage>203</lpage>
        <pub-id pub-id-type="pmid">15572068</pub-id>
      </element-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
          <name>
            <surname>Duprat</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Kaas</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Tranne</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Thiriot</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>G.</given-names>
          </name>
        </person-group>
        <article-title>IMGT unique numbering for MHC groove G-DOMAIN and MHC superfamily (MhcSF) G-LIKE-DOMAIN</article-title>
        <source>Dev. Comp. Immunol.</source>
        <year>2005</year>
        <volume>29</volume>
        <fpage>917</fpage>
        <lpage>938</lpage>
        <pub-id pub-id-type="pmid">15936075</pub-id>
      </element-citation>
    </ref>
    <ref id="B52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT unique numbering for the Variable (V), Constant (C), and Groove (G) domains of IG, TR, MH, IgSF, and MhSF</article-title>
        <source>Cold Spring Harb Protoc.</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>633</fpage>
        <lpage>642</lpage>
      </element-citation>
    </ref>
    <ref id="B53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ruiz</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT gene identification and Colliers de Perles of human immunoglobulins with known 3D structures</article-title>
        <source>Immunogenetics</source>
        <year>2002</year>
        <volume>53</volume>
        <fpage>857</fpage>
        <lpage>883</lpage>
        <pub-id pub-id-type="pmid">11862387</pub-id>
      </element-citation>
    </ref>
    <ref id="B54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kaas</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT Colliers de Perles: standardized sequence-structure representations of the IgSF and MhcSF superfamily domains</article-title>
        <source>Curr. Bioinformat.</source>
        <year>2007</year>
        <volume>2</volume>
        <fpage>21</fpage>
        <lpage>30</lpage>
      </element-citation>
    </ref>
    <ref id="B55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kaas</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Ehrenmann</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>IG, TR and IgSf, MHC and MhcSF: what do we learn from the IMGT Colliers de Perles</article-title>
        <source>Brief Funct. Genomic. Proteomic.</source>
        <year>2007</year>
        <volume>6</volume>
        <fpage>253</fpage>
        <lpage>264</lpage>
        <pub-id pub-id-type="pmid">18208865</pub-id>
      </element-citation>
    </ref>
    <ref id="B56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M-P.</given-names>
          </name>
        </person-group>
        <article-title>IMGT Collier de Perles for the Variable (V), Constant (C), and Groove (G) domains of IG, TR, MH, IgSF, and MhSF</article-title>
        <source>Cold Spring Harbor Protoc.</source>
        <year>2011</year>
        <volume>6</volume>
        <fpage>643</fpage>
        <lpage>651</lpage>
      </element-citation>
    </ref>
    <ref id="B57">
      <label>57.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>De</surname>
            <given-names>RK</given-names>
          </name>
          <name>
            <surname>Tomar</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Immunoinformatics of the V, C and G domains: IMGT® definitive system for IG, TR and IgSF, MH and MhSF</article-title>
        <source>Immunoinformatics: From Biology to Informatics</source>
        <year>2014</year>
        <volume>1184</volume>
        <edition>2nd edn</edition>
        <publisher-loc>Springer, NY</publisher-loc>
        <publisher-name>Humana Press</publisher-name>
        <fpage>59</fpage>
        <lpage>107</lpage>
      </element-citation>
    </ref>
    <ref id="B58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wain</surname>
            <given-names>H.M.</given-names>
          </name>
          <name>
            <surname>Bruford</surname>
            <given-names>E.A.</given-names>
          </name>
          <name>
            <surname>Lovering</surname>
            <given-names>R.C.</given-names>
          </name>
          <name>
            <surname>Lush</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Wright</surname>
            <given-names>M.W.</given-names>
          </name>
          <name>
            <surname>Povey</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>Guidelines for human gene nomenclature</article-title>
        <source>Genomics</source>
        <year>2002</year>
        <volume>79</volume>
        <fpage>464</fpage>
        <lpage>470</lpage>
        <pub-id pub-id-type="pmid">11944974</pub-id>
      </element-citation>
    </ref>
    <ref id="B59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gray</surname>
            <given-names>K.A.</given-names>
          </name>
          <name>
            <surname>Daugherty</surname>
            <given-names>L.C.</given-names>
          </name>
          <name>
            <surname>Gordon</surname>
            <given-names>S.M.</given-names>
          </name>
          <name>
            <surname>Seal</surname>
            <given-names>R.L.</given-names>
          </name>
          <name>
            <surname>Wright</surname>
            <given-names>M.W.</given-names>
          </name>
          <name>
            <surname>Bruford</surname>
            <given-names>E.A.</given-names>
          </name>
        </person-group>
        <article-title>Genenames.org: the HGNC resources in 2013</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2013</year>
        <volume>41</volume>
        <fpage>D545</fpage>
        <lpage>D552</lpage>
        <pub-id pub-id-type="pmid">23161694</pub-id>
      </element-citation>
    </ref>
    <ref id="B60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Maglott</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Ostell</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Pruitt</surname>
            <given-names>K.D.</given-names>
          </name>
          <name>
            <surname>Tatusova</surname>
            <given-names>T.</given-names>
          </name>
        </person-group>
        <article-title>Entrez Gene: gene-centered information at NCBI</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2007</year>
        <volume>35</volume>
        <fpage>D26</fpage>
        <lpage>D31</lpage>
        <pub-id pub-id-type="pmid">17148475</pub-id>
      </element-citation>
    </ref>
    <ref id="B61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Flicek</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Amode</surname>
            <given-names>M.R.</given-names>
          </name>
          <name>
            <surname>Barrell</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Beal</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Billis</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Brent</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Carvalho-Silva</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Clapham</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Coates</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Fitzgerald</surname>
            <given-names>S.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Ensembl 2014</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2014</year>
        <volume>42</volume>
        <fpage>D749</fpage>
        <lpage>D755</lpage>
        <pub-id pub-id-type="pmid">24316576</pub-id>
      </element-citation>
    </ref>
    <ref id="B62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Harrow</surname>
            <given-names>J.L.</given-names>
          </name>
          <name>
            <surname>Steward</surname>
            <given-names>C.A.</given-names>
          </name>
          <name>
            <surname>Frankish</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Gilbert</surname>
            <given-names>J.G.</given-names>
          </name>
          <name>
            <surname>Gonzalez</surname>
            <given-names>J.M.</given-names>
          </name>
          <name>
            <surname>Loveland</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Mudge</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Sheppard</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Trevanion</surname>
            <given-names>S.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Vertebrate Genome Annotation browser 10 years on</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2014</year>
        <volume>42</volume>
        <fpage>D771</fpage>
        <lpage>D779</lpage>
        <pub-id pub-id-type="pmid">24316575</pub-id>
      </element-citation>
    </ref>
    <ref id="B63">
      <label>63.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Alamyar</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Giudicelli</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Duroux</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Ossipow</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Fisher</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Antibody V and C domain sequence, structure and interaction analysis with special reference to IMGT®</article-title>
        <source>Monoclonal Antibodies: Methods and Protocols</source>
        <year>2014</year>
        <volume>1131</volume>
        <edition>2nd edn</edition>
        <publisher-loc>NY</publisher-loc>
        <publisher-name>Humana Press, Springer Science+Business Media, LLC</publisher-name>
        <fpage>337</fpage>
        <lpage>381</lpage>
      </element-citation>
    </ref>
    <ref id="B64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shirai</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Prades</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Vita</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Marcatili</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Popovic</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Overington</surname>
            <given-names>J.P.</given-names>
          </name>
          <name>
            <surname>Hirayama</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Soga</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Tsunoyama</surname>
            <given-names>K.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Antibody informatics for drug discovery</article-title>
        <source>Biochim. Biophys. Acta</source>
        <year>2014</year>
        <volume>1844</volume>
        <fpage>2002</fpage>
        <lpage>2015</lpage>
        <pub-id pub-id-type="pmid">25110827</pub-id>
      </element-citation>
    </ref>
    <ref id="B65">
      <label>65.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Dübel</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Reichert</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>How to use IMGT® for therapeutic antibody engineering</article-title>
        <source>Handbook of Therapeutic Antibodies</source>
        <volume>1</volume>
        <edition>2nd edn</edition>
        <publisher-loc>KGaA, Weinheim</publisher-loc>
        <publisher-name>Wiley-VCH Verlag GmbH &amp; Co.</publisher-name>
        <fpage>229</fpage>
        <lpage>263</lpage>
      </element-citation>
    </ref>
    <ref id="B66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>Antibody informatics: IMGT®, the international ImMunoGeneTics information system®</article-title>
        <source>Microbiol. Spect.</source>
        <year>2014</year>
        <volume>2</volume>
        <fpage>1</fpage>
        <lpage>14</lpage>
      </element-citation>
    </ref>
    <ref id="B67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kaas</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <article-title>T cell receptor/peptide/MHC molecular characterization and standardized pMHC contact sites in IMGT/3Dstructure-DB</article-title>
        <source>In Silico Biol.</source>
        <year>2005</year>
        <volume>5</volume>
        <fpage>505</fpage>
        <lpage>528</lpage>
        <pub-id pub-id-type="pmid">16268793</pub-id>
      </element-citation>
    </ref>
    <ref id="B68">
      <label>68.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Kaas</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Duprat</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Tourneur</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Schoenbach</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ranganathan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Brusic</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>IMGT standardization for molecular characterization of the T cell receptor/peptide/MHC complexes</article-title>
        <source>Immunoinformatics, Immunomics Reviews</source>
        <year>2008</year>
        <publisher-loc>Springer, NY</publisher-loc>
        <publisher-name>Series of Springer Science and Business Media LLC</publisher-name>
        <fpage>19</fpage>
        <lpage>49</lpage>
      </element-citation>
    </ref>
    <ref id="B69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rose</surname>
            <given-names>P.W.</given-names>
          </name>
          <name>
            <surname>Bi</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Bluhm</surname>
            <given-names>W.F.</given-names>
          </name>
          <name>
            <surname>Christie</surname>
            <given-names>C.H.</given-names>
          </name>
          <name>
            <surname>Dimitropoulos</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Dutta</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>R.K.</given-names>
          </name>
          <name>
            <surname>Goodsell</surname>
            <given-names>D.S.</given-names>
          </name>
          <name>
            <surname>Prlic</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Quesada</surname>
            <given-names>M.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The RCSB Protein Data Bank: new resources for research and education</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2013</year>
        <volume>41</volume>
        <fpage>D475</fpage>
        <lpage>D482</lpage>
        <pub-id pub-id-type="pmid">23193259</pub-id>
      </element-citation>
    </ref>
    <ref id="B70">
      <label>70.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Kabat</surname>
            <given-names>E.A.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>T.T.</given-names>
          </name>
          <name>
            <surname>Perry</surname>
            <given-names>H.M.</given-names>
          </name>
          <name>
            <surname>Gottesman</surname>
            <given-names>K.S.</given-names>
          </name>
          <name>
            <surname>Foeller</surname>
            <given-names>C.</given-names>
          </name>
        </person-group>
        <source>Sequences of Proteins of Immunological Interest, Washington, DC: U.S. Department of Health and Human Services (USDHHS)</source>
        <year>1991</year>
        <publisher-name>National Institute of Health NIH Publication</publisher-name>
        <fpage>91</fpage>
        <lpage>3242</lpage>
      </element-citation>
    </ref>
    <ref id="B71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ghia</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Stamatopoulos</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Belessi</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Moreno</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Stilgenbauer</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Stevenson</surname>
            <given-names>F.I.</given-names>
          </name>
          <name>
            <surname>Davi</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Rosenquist</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia</article-title>
        <source>Leukemia</source>
        <year>2007</year>
        <volume>21</volume>
        <fpage>1</fpage>
        <lpage>3</lpage>
        <pub-id pub-id-type="pmid">17167526</pub-id>
      </element-citation>
    </ref>
    <ref id="B72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jefferis</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P</given-names>
          </name>
        </person-group>
        <article-title>Human immunoglobulin allotypes: possible implications for immunogenicity</article-title>
        <source>MABS</source>
        <year>2009</year>
        <volume>1</volume>
        <fpage>332</fpage>
        <lpage>338</lpage>
        <pub-id pub-id-type="pmid">20073133</pub-id>
      </element-citation>
    </ref>
    <ref id="B73">
      <label>73.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Lefranc</surname>
            <given-names>M.-P.</given-names>
          </name>
          <name>
            <surname>Lefranc</surname>
            <given-names>G.</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Christiansen</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Tait</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Human Gm, Km and Am allotypes and their molecular characterization: a remarkable demonstration of polymorphism</article-title>
        <source>Immunogenetics</source>
        <year>2012</year>
        <volume>882</volume>
        <publisher-loc>Springer, NY</publisher-loc>
        <publisher-name>Humana Press</publisher-name>
        <fpage>635</fpage>
        <lpage>680</lpage>
      </element-citation>
    </ref>
    <ref id="B74">
      <label>74.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dechavanne</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Guillonneau</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Chiappetta</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Sago</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Lévy</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Salnot</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Guitard</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Ehrenmann</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Broussard</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Chafey</surname>
            <given-names>P.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Mass spectrometry detection of G3m and IGHG3 alleles and follow-up of differential mother and neonate IgG3</article-title>
        <source>PLoS One</source>
        <year>2012</year>
        <volume>7</volume>
        <fpage>e46097</fpage>
        <pub-id pub-id-type="pmid">23049948</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
